Saturday 17 October 2026 Export TRDA’s income statement to Excel — free account

Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $25.4 million, down 87.9% from fiscal 2024. In the quarter to June 2026, revenue fell 54.0%, EPS grew 2.88% and free cash flow fell 9.10%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

4.36 0.42 −8.79%

Follow TRDA

Alert me

Market cap: $186.1M
P/E: 0.0×
Fwd P/E: −1.6×
Dividend yield: —
F-score: 3/9
Altman Z: 2.15
Beneish M: −6.07
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	—	3	2	2
ROE Full definition →		(27.11%)	(39.13%)	(48.28%)	(54.09%)
ROA Full definition →		(21.39%)	(31.81%)	(40.42%)	(44.35%)
ROIC Full definition →		(547.44%)	(1,009.37%)	(697.14%)	(1,060.24%)
Return on Tangible Assets Full definition →		(32.06%)	(49.72%)	(65.35%)	(76.38%)
Average Days of Receivables Full definition →		7.10	16.90	50.06	63.56
Free Cash Flow per Share Full definition →		(3.13)	(3.13)	(3.15)	(3.18)
Free Cash Flow Full definition →		(129.80)	(129.55)	(131.64)	(134.35)
Capital Expenditures Full definition →		(1.88)	(1.04)	0.06	0.32
Other line items
Cash ROIC Full definition →		(19.44%)	(21.50%)	(25.04%)	(29.44%)
Accounts Receivable Turnover Full definition →		32.39	10.47	4.05	4.70
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		(0.03)	(0.01)	0.01	0.01
Research and Development Expense of Revenue Full definition →		230.36%	559.65%	2,496.50%	3,003.44%
Selling, General and Administrative Expense of Revenue Full definition →		67.23%	161.48%	712.79%	863.64%
Share Based Compensation of Revenue Full definition →		32.43%	77.14%	335.76%	413.32%
Operating CF/Net income Full definition →		1.24	0.89	0.79	0.81
Depreciation/Fixed assets Full definition →		(0.16)	0.06	0.17	0.24
Capex/Depreciation Full definition →		1.40	(2.45)	0.05	0.23
Revenue per Share Full definition →		1.48	0.61	0.14	0.11
Operating CF per Share Full definition →		(3.08)	(3.11)	(3.15)	(3.19)
Capex per Share Full definition →		(0.05)	(0.03)	0.00	0.01
Capex to Sales Full definition →		0.03	0.04	(0.01)	(0.07)

Show all line items

Columns are period end dates

Stockrow Weekly